amivantamab
janssen,genmab,eioc oncology
['chrysalis,(-chrysalis2),(-chrysalis-2),(-chrysalis 2)', 'nsclc', 'sclc']
chrysalis results reported on the use of amivantamab monotherapy in patients with nsclc with metex14. amivantamab demonstrated activity in patients who were treated and were not treated with a prior met inhibitor. #asco2022 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"